MedPath

Music to Reduce Use of Smoking in Patients With Schizophrenia

Not Applicable
Completed
Conditions
Smoking, Tobacco
Schizophrenia
Nicotine Dependence
Interventions
Behavioral: Music session
Registration Number
NCT03190161
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • clinician verification diagnosis of Schizophrenia or Schizoaffective Disorder
  • smoked at least 10 cigarettes per day for the past month
  • score of 4 or more on the Fagerstrom Test for Nicotine Dependence73
  • psychiatric stability (e.g., no psychiatric hospitalizations within the last year, no expectation for medication change during study participation, no active suicidal ideation, no symptoms that interfere with ability to participate in study activities)
  • the capacity to participate in the informed consent process
Read More
Exclusion Criteria
  • being medically unstable (e.g., medical condition that requires frequent medical appointments or hospitalizations and interferes with ability to participate in study activities)
  • report active substance abuse or testing positive drug or alcohol use
  • taking bupropion, varenicline, nicotine replacement products and/or involved in any other smoking cessation treatment
  • participating in any treatment or activity that includes music as a focus
  • having a seizure disorder, other neurological illnesses, or a family history of seizures
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Schizophrenia PatientsMusic sessionClinician verification diagnosis of Schizophrenia or Schizoaffective Disorder
Primary Outcome Measures
NameTimeMethod
Questionnaire of Smoking Urges-Brief (QSU-B) Post Music Session1 Day

Measures Cravings Post Music Session

Snaith-Hamilton Pleasure Scale (SHAPS)1 Day

Measures Pleasure Pre Music Session

Pleasure Rating Scale (PRS) Post Music Session1 Day

Measures Pleasure Post Music Session

Minnesota Nicotine Withdrawal Scale (MNWS) Post Music Session1 Day

Measures Withdrawal Post Music Session

Questionnaire of Smoking Urges-Brief (QSU-B)1 Day

Measures Cravings Pre Music Session

Snaith-Hamilton Pleasure Scale (SHAPS) Post Music Session1 Day

Measures Pleasure Post Music Session

Pleasure Rating Scale (PRS)1 Day

Measures Pleasure Pre Music Session

Minnesota Nicotine Withdrawal Scale (MNWS)1 Day

Measures Withdrawal Pre Music Session and Post Music Session

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath